| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/26/2001 | US6251852 Combination therapy for reducing the risks associated with cardiovascular disease |
| 06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251630 Polynucleotide encoding member of ribonuclease family of defined amino acid sequence; diagnosis; bacteriostats; bactericides; vaccines; treatment of otitis media, pneumonia, conjunctivitis, bacteremia, meningitis, sinusitis, and others |
| 06/26/2001 | US6251598 Methods for diagnosing sepsis |
| 06/26/2001 | US6251585 Assay and reagents for identifying anti-proliferative agents |
| 06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
| 06/26/2001 | US6251434 Preparations of non-steroidal analgesics |
| 06/26/2001 | US6251426 Ibuprofen-containing softgels |
| 06/26/2001 | US6251419 Membrane system for controlled tissue regeneration in cases of diseases of the periodontium |
| 06/26/2001 | US6251418 Delivering and implanting pellets containing a drug into the myocardial tissue; treating restenosis |
| 06/26/2001 | US6251400 Comprising limonin and/or nomilin, and a tocotrienol |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/26/2001 | US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/22/2001 | CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/21/2001 | WO2001044808A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 06/21/2001 | WO2001044514A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044295A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044274A1 Lipopeptides as antibacterial agents |
| 06/21/2001 | WO2001044272A2 Daptomycin analogs as antibacterial agents |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044198A1 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043774A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
| 06/21/2001 | WO2001043754A2 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases |
| 06/21/2001 | WO2001043751A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | WO2001043750A1 Phospholipid compositions as anti-inflammation agents |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043737A1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
| 06/21/2001 | WO2001043732A2 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 06/21/2001 | WO2001043731A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 06/21/2001 | WO2001043712A1 Catechol oximes and their use in cosmetic and dermatological preparations |
| 06/21/2001 | WO2001043704A1 A skin care composition that mediates cell to cell communication |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | WO2001026623A3 Treatment of fatigue, head injury and stroke |
| 06/21/2001 | WO2001019871A3 Delivery system for antidandruff agent |
| 06/21/2001 | WO2001017527A9 Preventive and therapeutic agents for eye diseases |
| 06/21/2001 | WO2001014535A3 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 06/21/2001 | WO2001013892A3 Large porous particles by spray-drying |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2000078972A8 Regulation with binding cassette transporter protein abc1 |
| 06/21/2001 | WO2000071103A3 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 06/21/2001 | WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/21/2001 | WO2000058472A8 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 06/21/2001 | WO2000055345A9 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 06/21/2001 | US20010004644 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 06/21/2001 | US20010004640 Compound such as 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7 -carboxylate, with a compound having diuretic activity or a compound having calcium antagonistic activity |
| 06/21/2001 | US20010004529 Compositions to enhance the efficacy and safety of bio-pharmaceutical drugs |
| 06/21/2001 | US20010004458 Rapidly disintegrating pellets |
| 06/21/2001 | DE19960105A1 Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen Catecholoxime and their use in cosmetic and dermatological preparations |
| 06/21/2001 | DE19959546A1 Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen A pharmaceutical preparation for treatment of tumor diseases |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
| 06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394350A1 Lipopeptides as antibacterial agents |
| 06/21/2001 | CA2394269A1 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 06/21/2001 | CA2394210A1 Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2393907A1 Novel lipopeptides as antibacterial agents |
| 06/21/2001 | CA2393808A1 Anti-cancer synthetic oligonucleotides |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2392766A1 Novel helicobacter pylori-binding substances and use thereof |
| 06/21/2001 | CA2390821A1 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/20/2001 | EP1108738A2 Immunostimulating carrier for vaccines |
| 06/20/2001 | EP1108436A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis |
| 06/20/2001 | EP1108428A2 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108427A2 Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108068A1 T-type calcium channel |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |